A detection method for Naoxin'an capsules
The content of salvianolic acid B was determined by ultrasonic treatment with methanol and liquid chromatography, which solved the problem that the content of the ingredients in Naoxin'an capsules could not be accurately controlled by traditional methods, and achieved controllable and consistent capsule quality.
Patent Information
- Application Number
- CN202410510497.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-26
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-04-26
AI Technical Summary
Traditional methods for preparing brain-calming capsules cannot accurately control the specific content of their ingredients, making it impossible to establish a complete quality control method.
The amount of tanshinone added to Naoxin'an capsules was controlled by measuring the content of tanshinone B in methanol ultrasonic treatment combined with liquid chromatography, thereby controlling the quality of the capsules.
This method enables rapid and accurate determination of the content of salvianolic acid B in Naoxin'an capsules, ensuring the controllability and consistency of capsule quality.
Smart Images

Figure CN118311174B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of pharmaceutical testing technology, and in particular to a testing method for Naoxin'an capsules. Background Technology
[0002] Naoxin'an Capsules are a traditional Chinese medicine. Visually, they are hard capsules containing orange-yellow to brownish-yellow powder; they have a bitter taste. The main ingredients include Astragalus membranaceus, Codonopsis pilosula, Saffron, Panax notoginseng, Salvia miltiorrhiza, Pueraria lobata, Ligusticum chuanxiong, Curcuma longa, processed Polygonum multiflorum, Haliotis diversicolor, Spatholobus suberectus, Gastrodia elata, Borneol, Prunus persica, Arisaema cum bile, Buthus martensii, Scolopendra subspinipes, artificial musk, and artificial bezoar. It is mainly suitable for the following conditions: invigorating qi and blood circulation, opening the orifices and unblocking the meridians. It is suitable for stroke, phlegm obstruction of the meridians, chest pain, and heart pain caused by qi deficiency and blood stasis, with symptoms such as dizziness, hemiplegia, chest tightness, heart pain, palpitations, and shortness of breath. It can also be considered for patients in the recovery period of ischemic stroke and patients with angina pectoris due to coronary heart disease if they experience the above symptoms. However, traditional methods of preparing Naoxin'an Capsules cannot accurately control the specific content of any component in the capsules, making it difficult to establish a complete quality control method. Summary of the Invention
[0003] The main objective of this invention is to propose a detection method for Naoxin'an capsules, and to design a detection method for Naoxin'an capsules.
[0004] The technical solution of this invention to solve the above-mentioned technical problems is to provide a method for detecting Naoxin'an capsules, comprising the following steps:
[0005] Extracts from Naoxin'an Capsules:
[0006] Place the Naoxin'an capsule powder in methanol, sonicate, cool, weigh again, replenish the lost weight with methanol, shake well, filter, and collect the filtrate.
[0007] Determination of the content of salvianolic acid B:
[0008] Pipette 10 μL of the filtrate into the liquid chromatograph and determine its composition.
[0009] The liquid chromatography conditions were as follows: octadecylsilane-bonded silica gel was used as the stationary phase; acetonitrile was used as mobile phase A, and 0.1% phosphoric acid solution was used as mobile phase B for gradient elution. The elution procedure is as follows: Flow rate: 1.0 mL / min; Detection wavelength: 286 nm; Column temperature: 30 °C.
[0010] Furthermore, in the extraction step of the aforementioned Naoxin'an capsules,
[0011] Take 1g of Naoxin'an capsule powder, accurately weigh it, place it in a stoppered conical flask, accurately add 25mL-100mL of 80% methanol, seal tightly, weigh it, sonicate for 15-60 minutes, cool, weigh it again, replenish the lost weight with 80% methanol, shake well, filter, and collect the filtrate.
[0012] Furthermore, in the extraction step of the Naoxin'an capsules;
[0013] The ultrasonic power of the ultrasonic treatment is 480W, and the ultrasonic frequency is 40KHz.
[0014] Furthermore, the detection method for the Naoxin'an capsules also includes: thin-layer chromatography identification of *Spatholobus suberectus*.
[0015] Take 5 μL of the filtrate and spot it on a silica gel G thin-layer plate. Develop the plate using ethyl toluene-formic acid as the developing solvent. Remove the plate, air dry it, spray it with 5% vanillin-sulfuric acid solution, heat it at 105℃ for about 5 minutes, and examine it under ultraviolet light.
[0016] Furthermore, in the step of thin-layer chromatography identification of *Spatholobus suberectus*, the ratio of toluene: ethyl formate: formic acid is 7:3:0.5.
[0017] The technical solution of this invention allows for the rapid and accurate determination of the content of salvianolic acid B in Naoxin'an capsules. Since salvianolic acid B in Naoxin'an capsules is entirely derived from Danshen (Salvia miltiorrhiza), the content of salvianolic acid B in Naoxin'an capsules can be controlled by controlling the amount of Danshen added, thereby controlling the content of salvianolic acid B in Naoxin'an capsules and achieving quality control of Naoxin'an capsules. Attached Figure Description
[0018] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on the structures shown in these drawings without creative effort.
[0019] Figure 1 This is a flowchart of the detection method for the Naoxin'an capsules described in this invention;
[0020] Figure 2 This is the HPLC chromatogram of the salvianolic acid B reference standard used in the negative control test of this invention;
[0021] Figure 3 This is the HPLC chromatogram of the Naoxin'an Capsule test sample of the present invention;
[0022] Figure 4 This is the HPLC chromatogram of the negative sample of the Naoxin'an Capsules of the present invention;
[0023] Figure 5 This is an HPLC chromatogram of the salvianolic acid B reference standard used for the content determination of three batches of Naoxin'an capsules in this invention;
[0024] Figure 6 The image shows the HPLC chromatogram of the Naoxin'an Capsules (batch number: 20230917-1) of this invention.
[0025] Figure 7 The image shows the HPLC chromatogram of the Naoxin'an Capsules (batch number: 20230917-2) of this invention.
[0026] Figure 8 The image shows the HPLC chromatogram of the Naoxin'an Capsules (batch number: 20230918-1) of this invention.
[0027] Figure 9 The image shows the HPLC chromatogram of the Naoxin'an Capsules (batch number: 20230918-2) of this invention.
[0028] Figure 10 The image shows the HPLC chromatogram of the Naoxin'an Capsules (batch number: 20230919-1) of this invention.
[0029] Figure 11 This is the HPLC chromatogram of the Naoxin'an Capsules (batch number: 20230919-2) of the present invention. Detailed Implementation
[0030] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only a part of the embodiments of the present invention, and not all of them. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0031] It should be noted that all directional indications (such as up, down, left, right, front, back, etc.) in the embodiments of the present invention are only used to explain the relative positional relationship and movement of each component in a certain specific posture (as shown in the figure). If the specific posture changes, the directional indication will also change accordingly.
[0032] Furthermore, in this invention, descriptions involving "first," "second," etc., are for descriptive purposes only and should not be construed as indicating or implying their relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one of that feature. In the description of this invention, "several" or "a plurality of" means at least two, such as two, three, etc., unless otherwise explicitly specified.
[0033] In this invention, unless otherwise explicitly specified and limited, the terms "connection," "fixed," etc., should be interpreted broadly. For example, "fixed" can mean a fixed connection, a detachable connection, or an integral part; it can mean a mechanical connection or an electrical connection; it can mean a direct connection or an indirect connection through an intermediate medium; it can mean the internal communication of two components or the interaction between two components, unless otherwise explicitly limited. Those skilled in the art can understand the specific meaning of the above terms in this invention according to the specific circumstances.
[0034] Furthermore, the technical solutions of the various embodiments of the present invention can be combined with each other, but only if they are feasible for those skilled in the art. If the combination of technical solutions is contradictory or cannot be implemented, it should be considered that such combination of technical solutions does not exist and is not within the scope of protection claimed by the present invention.
[0035] This invention proposes a detection method for Naoxin'an capsules, aiming to design a detection method for Naoxin'an capsules.
[0036] Reagents and instruments:
[0037] Instruments: Waters 2695 / 2996 high performance liquid chromatograph, Empower 3 workstation.
[0038] Column: ZORBAX SB-C18 StableBond Analytical 4.6×250mm 5-Micron;
[0039] Reagents: Acetonitrile was of chromatographic grade, water was purified water, and all other reagents were of analytical grade.
[0040] CN-20 Digital Ultrasonic Cleaner (480W power, 40kHz frequency, Beijing Desay Zhiyuan Trading Co., Ltd.)
[0041] Reference standard: Tanshinone B was provided by the National Institutes for Food and Drug Control (batch number: 110562-200302) for content determination.
[0042] The detection method for the Naoxin'an capsule proposed in this invention will be described below in specific embodiments:
[0043] Example 1, as Figure 1 As shown, a method for detecting Naoxin'an capsules includes the following steps:
[0044] Step 1: Extraction from Naoxin'an Capsules:
[0045] Place the Naoxin'an capsule powder in methanol, sonicate, cool, weigh again, replenish the lost weight with methanol, shake well, filter, and collect the filtrate.
[0046] Step 2: Determination of the content of salvianolic acid B:
[0047] Pipette 10 μL of the filtrate into the liquid chromatograph and determine its composition.
[0048] The liquid chromatography conditions were as follows: octadecylsilane-bonded silica gel was used as the stationary phase; acetonitrile was used as mobile phase A, and 0.1% phosphoric acid solution was used as mobile phase B for gradient elution.
[0049] The elution procedure is as follows: Flow rate: 1.0 mL / min; Detection wavelength: 286 nm; Column temperature: 30 °C.
[0050] Furthermore, in the extraction step of the aforementioned Naoxin'an capsules,
[0051] Take 1g of Naoxin'an capsule powder, accurately weigh it, place it in a stoppered conical flask, accurately add 25mL-100mL of 80% methanol, seal tightly, weigh it, sonicate for 15-60 minutes, cool, weigh it again, replenish the lost weight with 80% methanol, shake well, filter, and collect the filtrate.
[0052] Furthermore, in the extraction step of the Naoxin'an capsules;
[0053] The ultrasonic power of the ultrasonic treatment is 480W, and the ultrasonic frequency is 40KHz.
[0054] Furthermore, the detection method for the Naoxin'an capsules also includes:
[0055] Step 3: Thin-layer chromatography identification of *Spatholobus suberectus*:
[0056] Take 5 μL of the filtrate and spot it onto a silica gel G thin-layer plate. Develop the plate using ethyl toluene-formate-formic acid as the developing solvent. Remove the plate, air dry, spray with 5% vanillin-sulfuric acid solution, heat at 105℃ for about 5 minutes, and examine under ultraviolet light (365 nm). In the chromatogram of the test sample, spots of the same color appear at the corresponding positions as those of the reference medicinal material.
[0057] Specifically, the preparation of the control herbal solution was as follows: 2g of chicken blood vine herb was added to 40ml of ethanol and ultrasonically treated (power 480W, frequency 40KHz) for 30 minutes. The solution was filtered, the filtrate was evaporated to dryness, the residue was dissolved in 10ml of water, and extracted with 10ml of ethyl acetate by shaking. The ethyl acetate solution was evaporated to dryness, and the residue was dissolved in 1ml of methanol to obtain the control herbal solution.
[0058] Furthermore, in the step of thin-layer chromatography identification of *Spatholobus suberectus*, the ratio of toluene: ethyl formate: formic acid is 7:3:0.5.
[0059] Example 2
[0060] A method for detecting Naoxin'an capsules includes the following steps:
[0061] Step 1: Extraction from Naoxin'an Capsules
[0062] Solvent usage considerations:
[0063] Take 1g of Naoxin'an capsule powder, accurately weigh it, place it in a stoppered conical flask, and accurately add 25ml, 50ml, 75ml and 100ml of 80% methanol respectively. Seal tightly, weigh, sonicate (power 480W, frequency 40KHz) for 30 minutes, cool, weigh again, make up the lost weight with 80% methanol, shake well, filter, and collect the filtrate.
[0064] The content of salvianolic acid B was determined by liquid chromatography, and the test results are shown in Table 15-2.
[0065] Table 15-2 Results of the investigation on the amount of extraction solvent used The above experimental results show that the content determination results of the test sample prepared with 25ml of 80% methanol are lower than those prepared with 50ml, 75ml and 100ml of 80% methanol. Considering the need to save solvent and ensure that salvianolic acid B can be fully dissolved, the amount of 80% methanol used is selected as 50ml.
[0066] Example 3
[0067] A method for detecting Naoxin'an capsules includes the following steps:
[0068] Step 1: Extraction from Naoxin'an Capsules
[0069] Ultrasonic extraction time study:
[0070] Method 1: Accurately weigh 1g of Naoxin'an capsule powder and place it in a stoppered conical flask. Accurately add 50mL of 80% methanol, seal tightly, and weigh. Sonicate (480W, 40kHz) for 15 minutes, cool, and weigh again. Make up the lost weight with 80% methanol, shake well, filter, and collect the filtrate. Determine the content of salvianolic acid B by liquid chromatography. The results are shown in Table 15-3.
[0071] Method 2: Accurately weigh 1g of Naoxin'an capsule powder and place it in a stoppered conical flask. Accurately add 50mL of 80% methanol, seal tightly, and weigh. Sonicate (480W, 40kHz) for 30 minutes, cool, and weigh again. Make up the lost weight with 80% methanol, shake well, filter, and collect the filtrate. Determine the content of salvianolic acid B by liquid chromatography. The results are shown in Table 15-3.
[0072] Method 3: Accurately weigh 1g of Naoxin'an capsule powder, place it in a stoppered conical flask, accurately add 50mL of 80% methanol, seal tightly, weigh, and sonicate (power 480W, frequency 40KHz) for 45 minutes. Cool, weigh again, and replenish the lost weight with 80% methanol. Shake well, filter, and collect the filtrate. Determine the content of salvianolic acid B by liquid chromatography. The test results are shown in Table 15-3.
[0073] Method 4: Accurately weigh 1g of Naoxin'an capsule powder, place it in a stoppered conical flask, accurately add 50mL of 80% methanol, seal tightly, weigh, and sonicate (power 480W, frequency 40KHz) for 60 minutes. Cool, weigh again, and replenish the lost weight with 80% methanol. Shake well, filter, and collect the filtrate. Determine the content of salvianolic acid B by liquid chromatography. The test results are shown in Table 15-3.
[0074] Table 15-3 Effect of different ultrasonic extraction times on salvianolic acid B content Results Analysis: As can be seen from the above experimental results, the content determination results of the test sample prepared by Method 1 are lower than those prepared by Methods 2, 3 and 4. Considering the need to save time and ensure that salvianolic acid B can be fully dissolved, Method 2 is adopted.
[0075] Example 4
[0076] A method for detecting Naoxin'an capsules includes the following steps:
[0077] Step 1: Extraction from Naoxin'an Capsules:
[0078] Take 1g of Naoxin'an capsule powder, accurately weigh it, place it in a stoppered conical flask, accurately add 25mL-100mL of 80% methanol, seal tightly, weigh it, sonicate for 15-60 minutes, cool, weigh it again, make up the lost weight with 80% methanol, shake well, filter, and collect the filtrate.
[0079] Step 2: Determination of the content of salvianolic acid B:
[0080] Take 10 μL of the filtrate and inject it into the liquid chromatograph to determine the content of salvianolic acid B;
[0081] The liquid chromatography conditions were as follows: octadecylsilane-bonded silica gel was used as the stationary phase; acetonitrile was used as mobile phase A, and 0.1% phosphoric acid solution was used as mobile phase B for gradient elution.
[0082] The elution procedure is as follows: Flow rate: 1.0 mL / min; Detection wavelength: 286 nm; Column temperature: 30 °C.
[0083] 1. Establish a linear relationship:
[0084] Take an appropriate amount of salvianolic acid B reference standard, accurately weigh it, and add 80% methanol to prepare a solution containing 0.02525 mg of salvianolic acid B per 1 mL.
[0085] Precisely and automatically pipette 3 μL, 5 μL, 7 μL, 10 μL, 15 μL, and 20 μL of the reference solution and inject them into the liquid chromatograph for determination. The test results are shown in Table 15-4.
[0086] Table 15-4 Results of Linear Range Examination A regression analysis was performed with peak area on the ordinate and injection volume on the abscissa, yielding a straight line. The regression equation is: y = 35327x - 24377, R0 2 =0.9935.
[0087] The above results indicate that within the sample injection range of 0.07575–0.505 μg, the peak area of salvianolic acid B exhibits a good linear relationship with the injection amount.
[0088] 2. Negative control test:
[0089] According to the prescription of Naoxin'an Capsules, a negative control sample lacking Danshen was prepared. The samples were then analyzed using the methods described above. The results showed that the retention time of Danshen B reference standard was basically the same as that of Danshen B in Naoxin'an Capsules. Figure 2 , Figure 3 , Figure 4 As shown, the negative test solution did not show a corresponding peak at the position of the salvianolic acid B chromatographic peak, indicating that salvianolic acid B in Naoxin'an capsules originates from Danshen (Salvia miltiorrhiza) in Naoxin'an capsules. This means that the content of salvianolic acid B in Naoxin'an capsules can be adjusted by regulating the content of Danshen during the preparation of Naoxin'an capsules.
[0090] 3. Precision test:
[0091] Take the reference solution and perform the above-described content determination method. Perform the determination six times consecutively using the same method. The test results are shown in Table 15-5.
[0092] Table 15-5 Precision test results: The experimental results show that the liquid chromatograph used has good precision in determining salvianolic acid B, with an RSD of 0.25%.
[0093] 4. Stability testing:
[0094] Take the same test solution (batch number: 20230917), operate according to the above content determination method, and measure the peak area at time intervals of 0, 2, 6, 8, 12 and 24 hours respectively. The test results are shown in Table 15-6.
[0095] Table 15-6 Results of stability test:
[0096] The experimental results show that the chromatographic peak area does not change significantly within 24 hours after the test solution is prepared, and the chemical properties of the test solution are stable within this time period.
[0097] 5. Reproducibility test:
[0098] Take 6 samples (batch number: 20230917) and perform the above-mentioned content determination method. The test results are shown in Table 15-7.
[0099] Table 15-7 Results of Repeatability Tests
[0100] The experimental results show that the above-mentioned method for determining the content of salvianolic acid B in the sample has good reproducibility.
[0101] 6. Spiking recovery test:
[0102] Take 0.5g of a sample of known accurate content of Naoxin'an Capsules (batch number: 20230917), accurately weigh it, place it in a stoppered conical flask, accurately add an appropriate amount of Danshensu B reference standard, and determine the content according to the above-mentioned content determination method. The test results are shown in Table 15-8.
[0103] Table 15-8 Results of Recovery Test
[0104] The experimental results show that the recovery rates of salvianolic acid B in the samples determined by the above-mentioned content determination method all meet the requirements.
[0105] The above experimental results show that the method for determining the content of salvianolic acid B is stable, reproducible, and has a recovery rate between 95% and 105%, and can be used as a method for determining the content of salvianolic acid B in samples.
[0106] 7. Column durability test:
[0107] Take the same sample solution and use different brands of chromatographic columns to investigate the effect of different brands of chromatographic columns on the content of salvianolic acid B. The experimental results are shown in Table 15-9.
[0108] Table 15-9 Effect of chromatographic column on the content of salvianolic acid B
[0109] Note: Column 1: ZORBAX SB-C18 StableBond Analytical 4.6×250mm 5-Micron;
[0110] Column 2: Agilent 5TC-189 (2) 250×4.6mm;
[0111] Column 3: Waters XBridge® 5μm 4.6×250mm Column.
[0112] The experimental results show that the three different brands of chromatographic columns had no significant effect on the determination of salvianolic acid B content.
[0113] 8. Content determination of three batches of Naoxin'an capsules:
[0114] Following the above content determination method, the content of salvianolic acid B in three batches (20230917, 20230918, and 20230919) of Naoxin'an capsules was determined, and the chromatograms are shown below. Figure 5 , Figure 6 , Figure 7 , Figure 8 , Figure 9 , Figure 10 , Figure 11 As shown, the test results are shown in Table 15-10.
[0115] Table 15-10 Results of the determination of salvianolic acid B content in three batches of Naoxin'an capsules
[0116] Content limit setting: The average value of salvianolic acid B in the three batches of products was 0.42 mg / capsule. Considering the needs of large-scale production and the different quality of the medicinal materials themselves, the content of salvianolic acid B in the finished product is set at not less than 0.34 mg / capsule.
[0117] Solvent usage considerations:
[0118] Accurately weigh 1g of Naoxin'an capsule powder and place it in a stoppered conical flask. Accurately add 25ml, 50ml, 75ml, and 100ml of 80% methanol respectively, seal tightly, and weigh. Sonicate (480W, 40kHz) for 30 minutes, cool, and weigh again. Make up the lost weight with 80% methanol, shake well, filter, and collect the filtrate.
[0119] The content of salvianolic acid B was determined by liquid chromatography, and the test results are shown in Table 15-2.
[0120] Table 15-2 Results of the investigation on the amount of extraction solvent used
[0121] The above experimental results show that the content determination results of the test sample prepared with 25ml of 80% methanol are lower than those prepared with 50ml, 75ml and 100ml of 80% methanol. Considering the need to save solvent and ensure that salvianolic acid B can be fully dissolved, the amount of 80% methanol used is selected as 50ml.
[0122] The above description is merely a preferred embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Any variations or substitutions that can be easily conceived by those skilled in the art within the technical scope disclosed in the present invention should be included within the scope of protection of the present invention. Therefore, the scope of protection of the present invention should be determined by the scope of the claims.
Claims
1. A method for detecting Naoxin'an capsules, characterized in that, Includes the following steps: Extracts from Naoxin'an Capsules: Place the Naoxin'an capsule powder in methanol, sonicate, cool, weigh again, replenish the lost weight with methanol, shake well, filter, and collect the filtrate. Determination of the content of salvianolic acid B: Pipette 10 μL of the filtrate into the liquid chromatograph and determine its composition. The liquid chromatography conditions were as follows: octadecylsilane-bonded silica gel was used as the stationary phase; acetonitrile was used as mobile phase A, and 0.1% phosphoric acid solution was used as mobile phase B for gradient elution. The elution procedure is as follows: ; Flow rate: 1.0 mL / min; Detection wavelength: 286 nm; Column temperature: 30 °C.
2. The detection method for Naoxin'an capsules according to claim 1, characterized in that, In the extraction steps of the aforementioned Naoxin'an capsules Take 1g of Naoxin'an capsule powder, accurately weigh it, place it in a stoppered conical flask, accurately add 25mL-100mL of 80% methanol, seal tightly, weigh it, sonicate for 15-60 minutes, cool, weigh it again, replenish the lost weight with 80% methanol, shake well, filter, and collect the filtrate.
3. The detection method for Naoxin'an capsules according to claim 1, characterized in that, In the extraction step of the aforementioned Naoxin'an capsules; The ultrasonic power of the ultrasonic treatment is 480W, and the ultrasonic frequency is 40KHz.
4. The detection method for Naoxin'an capsules according to claim 1, characterized in that, The detection method for Naoxin'an capsules also includes: thin-layer chromatography identification of chicken blood vine. Take 5 μL of the filtrate and spot it on a silica gel G thin-layer plate. Develop the plate using ethyl toluene-formic acid as the developing solvent. Remove the plate, air dry it, spray it with 5% vanillin-sulfuric acid solution, heat it at 105°C for about 5 minutes, and examine it under ultraviolet light.
5. The detection method for Naoxin'an capsules according to claim 4, characterized in that, In the step of thin-layer chromatography identification of *Spatholobus suberectus*, the ratio of toluene: ethyl formate: formic acid is 7:3:0.5.
Citation Information
Patent Citations
í«Naoxinaní» tablet in use for cardiovascular disease, cerebrovascular disease and preparation method
CN101049462A
Method for detecting salvia heart-soothing capsules
CN101982189A
